Literature DB >> 33431971

Optimal body size adjustment of L3 CT skeletal muscle area for sarcopenia assessment.

Brian A Derstine1, Sven A Holcombe2, Brian E Ross2, Nicholas C Wang2, Grace L Su2, Stewart C Wang2.   

Abstract

Measurements of skeletal muscle cross-sectional area (SMA) at the level of the third lumbar (L3) vertebra derived from clinical computed tomography (CT) scans are commonly used in assessments of sarcopenia, the loss of skeletal muscle mass and function associated with aging. As SMA is correlated with height and Body Mass Index (BMI), body size adjustment is necessary to fairly assess sarcopenic low muscle mass in individuals of different height and BMI. The skeletal muscle index, a widely used measure, adjusts for height as [Formula: see text] but uses no BMI adjustment. There is no agreed upon standard for body size adjustment. We extracted L3 SMA using non-contrast-enhanced CT scans from healthy adults, split into 'Under-40' and 'Over-40' cohorts. Sex-specific allometric analysis showed that height to the power of one was the optimal integer coefficient for height adjusted SMA in both males and females. We computed two height-adjusted measures [Formula: see text] and [Formula: see text], comparing their Pearson correlations versus age, height, weight, and BMI separately by sex and cohort. Finally, in the 'Under-40' cohort, we used linear regression to convert each height-adjusted measure into a z-score ([Formula: see text], [Formula: see text]) adjusted for BMI. [Formula: see text] was less correlated with height in both males and females ([Formula: see text], [Formula: see text] and [Formula: see text], [Formula: see text]) than [Formula: see text] ([Formula: see text] and [Formula: see text], [Formula: see text]). [Formula: see text] was uncorrelated with BMI and weight, and minimally correlated with height in males and females ([Formula: see text], [Formula: see text] and [Formula: see text], [Formula: see text]). The final [Formula: see text] equation was: [Formula: see text], where [Formula: see text], [Formula: see text], [Formula: see text], and sex = 1 if male, 0 if female. We propose [Formula: see text] for optimal height adjustment and the [Formula: see text] score for optimal height and BMI adjustment. By minimizing correlations with height and BMI, the [Formula: see text] score produces unbiased assessments of relative L3 skeletal muscle area across the full range of body sizes.

Entities:  

Mesh:

Year:  2021        PMID: 33431971      PMCID: PMC7801425          DOI: 10.1038/s41598-020-79471-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

1.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

Authors:  J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Quantifying the effect of slice thickness, intravenous contrast and tube current on muscle segmentation: Implications for body composition analysis.

Authors:  Georg Fuchs; Yves R Chretien; Julia Mario; Synho Do; Matthias Eikermann; Bob Liu; Kai Yang; Florian J Fintelmann
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

3.  Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population.

Authors:  B A Derstine; S A Holcombe; R L Goulson; B E Ross; N C Wang; J A Sullivan; G L Su; S C Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Epidemiology of sarcopenia among the elderly in New Mexico.

Authors:  R N Baumgartner; K M Koehler; D Gallagher; L Romero; S B Heymsfield; R R Ross; P J Garry; R D Lindeman
Journal:  Am J Epidemiol       Date:  1998-04-15       Impact factor: 4.897

5.  Skeletal muscle analyses: agreement between non-contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation.

Authors:  Anne van der Werf; Ingeborg M Dekker; Martijn R Meijerink; Nicolette J Wierdsma; Marian A E de van der Schueren; Jacqueline A E Langius
Journal:  Clin Physiol Funct Imaging       Date:  2017-04-16       Impact factor: 2.273

6.  Sarcopenia and mortality after liver transplantation.

Authors:  Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal:  J Am Coll Surg       Date:  2010-06-26       Impact factor: 6.113

7.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.

Authors:  Liang-Kung Chen; Li-Kuo Liu; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Kamaruzzaman Shahrul Bahyah; Ming-Yueh Chou; Liang-Yu Chen; Pi-Shan Hsu; Orapitchaya Krairit; Jenny S W Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Panita Limpawattana; Chu-Sheng Lin; Li-Ning Peng; Shosuke Satake; Takao Suzuki; Chang Won Won; Chih-Hsing Wu; Si-Nan Wu; Teimei Zhang; Ping Zeng; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2014-02       Impact factor: 4.669

Review 8.  Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.

Authors:  J L A van Vugt; S Levolger; R W F de Bruin; J van Rosmalen; H J Metselaar; J N M IJzermans
Journal:  Am J Transplant       Date:  2016-04-04       Impact factor: 8.086

Review 9.  Measurement of skeletal muscle radiation attenuation and basis of its biological variation.

Authors:  J Aubrey; N Esfandiari; V E Baracos; F A Buteau; J Frenette; C T Putman; V C Mazurak
Journal:  Acta Physiol (Oxf)       Date:  2014-03       Impact factor: 6.311

10.  Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population.

Authors:  Brian A Derstine; Sven A Holcombe; Brian E Ross; Nicholas C Wang; Grace L Su; Stewart C Wang
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

View more
  6 in total

1.  CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma.

Authors:  Kyle J Lafata; Mustafa R Bashir; Mariana R DeFreitas; Amadu Toronka; Marybeth A Nedrud; Sarah Cubberley; Islam H Zaki; Brandon Konkel; Hope E Uronis; Manisha Palta; Dan G Blazer
Journal:  Abdom Radiol (NY)       Date:  2022-10-09

2.  Scaling of computed tomography body composition to height: relevance of height-normalized indices in patients with colorectal cancer.

Authors:  Justin C Brown; Steven B Heymsfield; Bette J Caan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-11-06       Impact factor: 12.910

3.  Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population.

Authors:  Sung Woo Moon; Sang Hoon Lee; Ala Woo; Ah Young Leem; Su Hwan Lee; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Moo Suk Park; Young Sam Kim; Chang Oh Kim; Song Yee Kim
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

4.  Impact of Sarcopenia and Bone Mineral Density on Implant Failure after Dorsal Instrumentation in Patients with Osteoporotic Vertebral Fractures.

Authors:  Harald Krenzlin; Leon Schmidt; Dragan Jankovic; Carina Schulze; Marc A Brockmann; Florian Ringel; Naureen Keric
Journal:  Medicina (Kaunas)       Date:  2022-05-31       Impact factor: 2.948

5.  Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.

Authors:  Ping'an Ding; Honghai Guo; Chenyu Sun; Shuya Chen; Peigang Yang; Yuan Tian; Scott Lowe; Qun Zhao
Journal:  Front Nutr       Date:  2022-09-02

6.  Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST.

Authors:  Ping'an Ding; Honghai Guo; Xiaoxiao He; Chenyu Sun; Scott Lowe; Rachel Bentley; Qin Zhou; Peigang Yang; Yuan Tian; Yang Liu; Li Yang; Qun Zhao
Journal:  BMC Gastroenterol       Date:  2022-08-26       Impact factor: 2.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.